Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR AI

Date Submitted: Aug 21, 2025
Date Accepted: Mar 13, 2026
Date Submitted to PubMed: Mar 16, 2026

The final, peer-reviewed published version of this preprint can be found here:

Immersive, Interactive, Intelligent Patient Educational System for Venous Thromboembolism (ChatVTE): Development and Validation Study

Liu Bb, Jin Zg, Zhang Zq, Wang H, Wang H, Zhang H, Li C, Qi F, Guo Yt

Immersive, Interactive, Intelligent Patient Educational System for Venous Thromboembolism (ChatVTE): Development and Validation Study

JMIR AI 2026;5:e82775

DOI: 10.2196/82775

PMID: 41941541

PMCID: 13052474

Development and Validation of ChatVTE: Immersive Interactive Intelligent Patient Educational System for Venous Thromboembolism

  • Bin bin Liu; 
  • Zhe geng Jin; 
  • Zhe qi Zhang; 
  • Hong Wang; 
  • Hao Wang; 
  • Hui Zhang; 
  • Changzhen Li; 
  • Fei Qi; 
  • Yu tao Guo

ABSTRACT

Background:

Effective patient education is crucial in preventing venous thromboembolism (VTE), improving patient outcomes, and reducing healthcare costs. Traditional educational methods, however, often lack engagement and fail to address individual patient needs comprehensively.

Objective:

This study aimed to develop and preliminarily validate an immersive, large language model (LLM)-based patient education system for VTE.

Methods:

An interactive intelligent patient education platform, ChatVTE, was engineered by integrating a retrieval-augmented large language model (LLM; Qwen1.5-7B) with Text-to-Speech (TTS) and Lip-Synchronization (Lip-Sync) technologies. The system’s performance was initially assessed through a comparative evaluation against Chat Generative Pre-trained Transformer (ChatGPT). This involved utilizing a standardized set of VTE-related questions, administered from December 10 to 31, 2024, with responses rigorously evaluated by four VTE domain experts using a 5-point Likert scale for accuracy, completeness, consistency, and safety. In a subsequent phase, a prospective cohort of 25 adult inpatients diagnosed with VTE was consecutively enrolled from the Departments of Pulmonary Vascular and Thrombotic Diseases and General Surgery at the Sixth Medical Center of the Chinese People’s Liberation Army General Hospital between March 1 and May 31, 2025. These participants engaged with the ChatVTE system throughout their inpatient stay and completed post-intervention assessments upon discharge.

Results:

Expert evaluation demonstrated ChatVTE’s superior performance over ChatGPT in terms of accuracy, completeness, consistency (all P<.001), and safety (P=.009). Among the 25 enrolled patients (mean age: 55.4±13.2 years), ChatVTE garnered high average scores (mean score >4.0/5.0) across 8 of 9 evaluated experience dimensions; however, the emotional support domain received a comparatively lower score (1.92/5.0).

Conclusions:

This study validates the feasibility of ChatVTE in the management of VTE patients, demonstrating its potential to enhance the quality of patient-provider interaction and the efficacy of knowledge dissemination. The system exhibits promising application prospects in both patient education and the facilitation of shared clinical decision-making.


 Citation

Please cite as:

Liu Bb, Jin Zg, Zhang Zq, Wang H, Wang H, Zhang H, Li C, Qi F, Guo Yt

Immersive, Interactive, Intelligent Patient Educational System for Venous Thromboembolism (ChatVTE): Development and Validation Study

JMIR AI 2026;5:e82775

DOI: 10.2196/82775

PMID: 41941541

PMCID: 13052474

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.